Introduction

In spite of being generally effective over several decades, antibacterial drugs have been counteracted by continuously developing bacterial resistance that reduced drug effectiveness in the treatment of infections [11]. Over the last three decades, pharmaceutical industries also committed to producing new antibiotics that have the ability to effectively suppress bacterial cell wall synthesis, protein synthesis, and DNA replication [34]. However, despite these developments, bacterial resistance to conventional antibiotics has continued to pose a crucial issue in health care that has significant impact on communities around the world [22]. Although community-acquired MRSA species are less resistant to antimicrobials than those identified with nosocomial settings, toxins as Panton-Valentine leukocidinare more likely to be produced (Hultén et al. 2018). The continuing proliferation of resistant bacterial strains within the population, e.g. in health care facilities, sports teams, military recruits, and day care centers for children, produces additional difficulties in reducing pathogens [24].

Nanoparticles of trace metals, such as Ag and Au that present unique features and extensive applications, are presented in diverse fields [49]. Therefore, the characteristics of these NPs have always been of great interest to many scientists [15]. Generally, NPs display properties completely different from those of their bulk counterparts [23, 26]. Silver nanoparticles (AgNPs) show high toxicity to various types of bacteria in the human body, which is mainly related to their large specific surface area and high reactivity [14, 29,30,31]. The broad antibacterial properties of Ag-NPs have encouraged researchers to employ these materials in biomedical applications [27, 48, 50, 54]. Various investigations have demonstrated the efficacy of Ag-NPs against Methicillin-sensitive Staphylococcus aureus (MSSA) [37, 52]. Nonetheless, the attempts of combined use of Ag-NPs and antibiotics as a curative tool of antibiotic-resistant bacterial infections are scarce. Rudramurthy et al. showed the synergistic effect between antimicrobial peptides and silver nanoparticles on Gram-negative bacteria [2]. Kora and Rastogi revealed that Ag-NPs coated with polyvinylpyrrolidone (PVP) develops stronger antibacterial activity when combined with established antibiotics, compared to those capped with citrate or SDS [15]. More recently, the positive impacts of using AgNPs together with topical antibiotics to treat bacterial infections were reported by [38]. Velusamy et al. also indicated that penicillin may contribute in increasing antibiotic effectiveness in combination with silver nanoparticles [8, 12].

In late 1990, the Pulsed Laser Ablation in Liquid (PLAL) technology began to get attention. It is a top-down physical method based on the premise of splitting metal ion bulk precursors into metal atoms, It has the crucial advantage of creating extremely stable and pure nanoparticles with a surface free of reactant residue ions for biological applications, as well as very inexpensive processing setup costs. The way that materials react to light depends on the laser beam's intensity and temperature. As a result of constant laser exposure to a material, a series of reactions including heating, melting, boiling, and plasma production occur [9, 10, 18, 42]. Synthesis of Ag-NPs using PLAL is considered one of the most significant prospective strategies that was shown to be useful for many applications, especially in human health care [51].

Many efforts have been devoted to synthesising Ag- and Au-NPs [25, 28, 32, 35, 55]. Nd–YAG lasers are preferred over other laser types due to their precise processing during laser ablation in liquid. The size of AgNPs could be controlled in liquid media in the form of stable colloidal silver solutions [9, 10, 39,40,41, 43]. These colloids usually consist of Ag-NPs of different sizes with several features, such as chemical stability, non-toxicity, and easy handling. Resizing and reshaping also can be achieved via the melting and fragmentation techniques [1, 4,5,6,7, 13, 20, 36, 39, 40].

Staphylococcus aureus is a worldwide significant bacteria and it is responsible for multiple diseases. Antibiotics were used to classify resistant strains of S. aureus, including methicillin-resistant S. aureus (MRSA). Due to the presence of the mecA gene integrated in the staphylococcal cassette chromosome mecA, the MRSA strain gains resistance. This gene encodes a penicillin-binding protein of 78 kD that enhances the inhibitory effect on bacterial cell wall [29,30,31]. Antibiotic-resistant bacteria, such as MRSA, could also spread to populations outside the hospital and result in a widespread disease [27], Maribel et al. 2009).

The increasing complexity of this issue makes it necessary not only to discover new antibiotics, but also to develop alternative non-antibiotic solutions [16, 46, 50]. The size and shape of AgNps have a high impact on their antibacterial activity. Some reports had recorded a high biocidal activity of anisotropic shape of silver nanoparticles [17, 44, 47] While others reported highest antibacterial activity of isotropic silver nanoparticles due to large surface area to volume ratio of spherical shapes [3, 19, 53].

The TEM of the experimentally prepared AgNps reveal formation of spherical shaped silver nanoparticles as shown in Fig. (3).

This study aims to prepare suspensions of AgNPs by laser ablation in liquid medium, compare their antibacterial activity against S. aureus with those of common antibiotics, and evaluate the antibacterial activity of AgNPs synthesized by laser ablation against methicillin-resistant Staphylococcus aureus bacteria (MRSA) with and without irradiation with visible 405 nm blue laser light. 

Experimental Procedure

Preparation and Characterization of the AgNPs

AgNPs were synthesised by pulsed laser ablation of pure Ag metal plates (ounces of 99.999%) placed at the bottom of a quartz vessel containing 1 ml of double deionised distilled water. The Q-switched Nd:YAG laser of 10 ns and various energies, in the range from 100 to1000 mj, was used. A lens with a 10 cm focal length was used to obtain a 1.2 mm diameter for laser spot by adjusting the height along the z-axis between the lens and the sample surface, as shown in Fig. (1). The proper laser energy density, 10 J/cm2, was chosen to ablate the AgNPs [29,30,31]. When the laser pulse strikes the Ag surface, a spark plume emerges, followed by a visible cloud of Ag particles, which are expanded and dispersed gradually through the liquid. This process can be recognised by the naked eye.

Fig. 1
figure 1

Experimental set-up for the synthesise of silver nanoparticles using Q-switched Nd:YAG laser

The synthesized AgNPs were characterized using various methods including; Transmission electron microscopy (JOEL, JEM 1400), Atomic Force Microscopy (AA2000,Angstrom, USA) and UV–Visible spectroscopy (Biotech Co., UK). Zeta potential (Brookhaven, zeta plus) tests were also carried out to explore the aggregation of silver nanoparticles in the suspension.

Examination of AgNPs Antibacterial Activity Against S. aureus

An AgNPs solution with a concentration of 60 µg/ml was prepared and its antimicrobial activity was examined based on the minimum inhibitory concentration (MIC). Different concentrations (120, 60, 30, 15 and 7.5 µg/ml) of this AgNPs solution were prepared by the two fold serial dilution method. The absorption spectrum was gained by a UV–Vis spectrophotometer. The antibacterial effects of the colloidal solutions were tested against S.aureus and compared with those of amoxicillin (25 µg), penicillin (10 µg), chloramphenicol (30 µg), and streptomycin (10 µg).

The disk diffusion method was used to examine the antimicrobial activity of each solution. Here, 50 µl of the solution was added to a sterilised filter paper and then incubated (UniMedica, China) at 37 °C until dry. An oven (Suarez, Brazil) was used for heating. Generally, S. aureus required relative humidity of 70% – 80%. The antimicrobial effects of different antibiotics were also tested by the Kirby–Bauer (disk diffusion test) method. Then, 40 µl of the solution with concentration of 60 µg/ml AgNPs was combined with the antibiotics mentioned above to investigate the synergetic effects of AgNPs and antibiotics.

The laser-enhanced antibacterial activity of AgNPs was assessed by subjecting the incubated resistant bacteria to 405 nm laser light at different exposure times (5, 10 and 15 min) and a power density of 0.1 W/cm2. MIC values were evaluated as the lowest NP concentration required to arrest the growth of bacteria in the test dish (i.e., the dish shows no turbidity) after incubation.

Results and Discussion

A remarkable colour change from yellow to brown (due to increases in nanoparticles density) was observed in the AgNPs colloidal solutions as the number of pulses used to prepare the solution by laser ablation increased from 100 to 1000. The absorption spectrum of AgNps colloidal suspension is given in Fig. (2). The absorption peak appears at wavelength much smaller than the incident light due to the surface plasmon resonance. The absorbance characteristics (height, width, and position) are strongly depends on the nanoparticle size. In this figure, the absorption peak which is located at 410 nm is correspond to presence of AgNps in the range in the range (20–30) nm [33, 45].

Fig. 2
figure 2

The UV–Vis absorption spectrum of silver nanoparticles (AgNPs) prepared by Nd:YAG laser

Moreover, the AgNPs colloidal solutions were chemically stable for a long time (months), as shown in Table 1. AgNPs prepared against the tested samples with high laser energy and low number of laser pulses did not have sufficient antibacterial activity. Thus, the activities of the AgNPs colloidal solutions with concentrations greater than100 µg/ml must be studied. Furthermore, AgNPs with different shapes and sizes may exhibit different antibacterial activities.

Table 1 Stability of AgNPs Prepared by Nd:YAG laser
Table 2 Zone of inhibition diameter for S.aureus treated with silver nanoparticles

TEM investigations revealed the formation of spherical AgNPs with average size of 14 nm, as shown in Fig. (3). The findings indicate that even if prepared with a higher number of laser pulses, NPs of higher density could be obtained.

Fig. 3
figure 3

Images generated by HRTEM of silver nanoparticles prepared by Nd:YAG laser. A) The size and morphology of AgNPs analysed using HRTEM, which confirmed spherical shaped silver nanoparticles with an average particle size of 14 nm. And, B) Magnified version for prepared AgNps

Furthermore, the shape, size and size distribution of the laser prepared AgNPs was examined by AFM. The AFM image in Fig. (4) shows AgNPs prepared by Nd:YAG laser of 400 mj with 1000 pulses while the corresponding histogram reveals a homogeneous size distribution of AgNPs in the range 10 to 30 nm with average size of about 14 nm.

Fig. 4
figure 4

AFM image and histogram of AgNPs prepared by 400 mj laser energy with 1000 pulses

The effect of a high-concentration of colloidal AgNPs prepared with 1000 laser pulses on S. aureus was studied. It is found that higher laser energies (> 600 mj) produce larger nanoparticle sizes which exhibited no noticeable effect on this type of bacteria. Whereas, lower laser energy of 400 mj leads to prepare effective colloidal solution of AgNPs. This energy produced AgNPs with smaller sizes in comparison with those obtained using high-energy laser. It was observed that one group of Staphylococcus bacteria is sensitive and affected by silver nanoparticles while another group is not affected by AgNPs and became resistant to AgNPs. Therefore, to activate plasmonic effects on their surface, the NPs were subjected to laser light. The antimicrobial activity (diameter of inhibition zone and MIC) of these laser-enhanced AgNPs on this group of resistant bacterium was investigated. Table (2) shows the inhibition zone of Staphylococcus in agar dishes treated with various concentrations of AgNPs prepared with 400 mj laser energy. The table reveals that the MIC for this group of bacteria is 60 µg/ml. The effect of the AgNPs is attributed to their penetration of the bacterial cell wall and generation of reactive oxygen species, leading to oxidative stress in bacterial cells.

The synergistic influence of antibiotics and AgNPs leads to enhancing the antibacterial activity, particularly against strains that have been proved to be resistant [21]. In this study, the synergistic effects of AgNPs with 4 separate antibiotics against S. aureus were studied based on the method of disc-diffusion. It was found that the diameter of inhibition zone increased in response to treatment with amoxicillin (25 µg), penicillin (10 µg), chloramphenicol (30 µg), and streptomycin (10 µg) from Himedia /India in the presence of the metallic nanoparticles at different concentrations (120, 60, 30, 15, 7.5) μg/ml, as demonstrated by the results listed in Table 3. This combined impact can result either from an increase in the bio-availability of the drug after conjugation in the cell membrane of bacteria or from the assimilation of both components. Recent studies have suggested that the AgNPs will act in two ways; in the first one, they can assault the cell membrane to destabilize it; in the second way, they, under synergetic influence with antibiotics, will easily cross the barrier of the cell membrane to demonstrate their bioactivity [29, 29, 30, 30, 31, 31, 56]. Table (3) presents the diameter of inhibition zone (DIZ) for AgNPs in combination with the antibiotics. The AgNPs could improve the antibacterial activity of all antibiotics tested and increased the diameter of the inhibition zone from 4 to 28 mm when added to penicillin. Figure (5) shows the agar dish treated with the combination of various Ag-NPs concentrations and penicillin.

Table 3 The DIZ values in millimeters of sensitive S. aureus bacteria treated with AgNPs alone and in combination with Penicillin (P), Amoxicillin (AX), Chloramphenicol (Ch), and Streptomycin (S)
Table 4 The antibacterial activity of silver nanoparticles on S.aureus before and after irradiating with laser light of 405 nm wavelength
Fig. 5
figure 5

Agar diffusion dish of sensitive Staphylococcus aureus bacteria treated with different concentrations of silver nanoparticles and Penicillin antibiotic

Finally, the effect of AgNPs on methicillin-resistant Staphylococcus aureus (MRSA) bacteria was investigated. No considerable effect was observed for all prepared concentrations of AgNPs. Therefore, a new strategy was adopted concerning irradiation AgNPs with diode laser light of 405 nm during the bacteria treatment. This strategy activates the plasmonic effect on the AgNPs surface [38]. The results showed promising antibacterial activity by irradiated AgNPs, including an increase in DIZ value to 25 mm and a decrease in MIC value from 60 µg/ml to 30 µg/ml.

The observed remarkable improvement in AgNps antibacterial activity by laser irradiation can be explained by the photo thermal effect of laser light, which leads to a rapid loss of cell membrane integrity [8, 12]. The photothermal effect is stimulated by the enhanced surface plasmon resonance which is activated by the strong absorption near 405 nm (as discussed earlier in the UV–Visible measurements) especially for smaller silver nanoparticles. Table (4) shows the antibacterial activity of AgNPs on Staphylococcus aureus before and after irradiation with 405 nm laser light.

Conclusions

Human infective S. aureus are shown here to be affected by AgNPs prepared by pulse laser ablation in liquid. The antibacterial effect of AgNPs depends on their size, shape, and concentration in its nano-suspension media. The prepared AgNPs with size distribution in the range 10 to 30 nm had a minimum inhibition concentration of 60 μg/ml and exhibit much higher antibacterial effects when applied synergistically with some antibiotics, compared with their effects alone. Notably, AgNPs synthesised in this study also showed enhanced antibacterial effects on S. aureus and reduce the inhibition zone from 25 to 12 mm when they are irradiated with a blue laser light of 405 nm for local activation against MRSA.